Anna Grenabo Bergdahl

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Patients Undergoing

Ejection Fraction

Top Venues

The Journal of urology

BJU international

This page only lists publications with an associated author ORCID identifier.

Publications

Anna Thor, Mette Pernille Myklebust, Anna Grenabo Bergdahl, Per-Olof Lundgren, Viktor Skokic, Bjarte Almås, Hege Sagstuen Haugnes, Torgrim Tandstad, Olof Akre, Gabriella Cohn-Cedermark, Olav Dahl, Anders Kjellman
miR-371a-3p Predicting Viable Tumor in Patients Undergoing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer: The SWENOTECA-MIR Study. The Journal of urology (2024)
Anna Thor, Mette Pernille Myklebust, Anna Grenabo Bergdahl, Per-Olof Lundgren, Viktor Skokic, Bjarte Almås, Hege Sagstuen Haugnes, Torgrim Tandstad, Olof Akre, Gabriella Cohn-Cedermark, Olav Dahl, Anders Kjellman
miR-371a-3p Predicting Viable Tumor in Patients Undergoing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer: The SWENOTECA-MIR Study. The Journal of urology (2024)
Anna Thor, Mette Pernille Myklebust, Anna Grenabo Bergdahl, Per-Olof Lundgren, Viktor Skokic, Bjarte Almås, Hege Sagstuen Haugnes, Torgrim Tandstad, Olof Akre, Gabriella Cohn-Cedermark, Olav Dahl, Anders Kjellman
miR-371a-3p Predicting Viable Tumor in Patients Undergoing RPLND for Metastatic Testicular Cancer: The SWENOTECA-MIR Study. The Journal of urology (2024)
Axel Gerdtsson, Gustav Torisson, Anna Thor, Anna Grenabo Bergdahl, Bjarte Almås, Ulf Håkansson, Magnus Törnblom, Helene F S Negaard, Ingrid Glimelius, Dag Halvorsen, Ása Karlsdóttir, Hege Sagstuen Haugnes, Signe Melsen Larsen, Göran Holmberg, Rolf Wahlqvist, Torgrim Tandstad, Gabriella Cohn-Cedermark, Olof Ståhl, Anders Kjellman
Validation of a prediction model for post-chemotherapy fibrosis in nonseminoma patients. BJU international (2023)
Anna Grenabo Bergdahl, Marianne Månsson, Göran Holmberg, Magnus Fovaeus
Robotic retroperitoneal lymph node dissection for testicular cancer at a national referral centre. BJUI compass 3 (5) (2022)